The molecular pathways underlying age-related memory changes remain unclear. There is a substantial genetic contribution to memory performance through life span. A recent study has implicated RbAp48, which mediates its effect on age-related memory decline by interacting with cyclic adenosine monophosphate responsive element binding protein (CREB)1 binding protein and influencing this histone acetylation pathway. To validate these findings, we tested whether genetic variants in RbAp48, CREB1, and CREBBP are associated with memory performance in 3 independent data sets consisting of 2674 cognitively healthy elderly individuals. Genetic variant rs2526690 in the CREBBP gene was significantly associated with episodic memory performance (p meta ¼ 3.7 Â 10 À4 ) in a multivariate model adjusted for age, sex, and apolipoprotein E status. Identifying genetic variants that modulate mechanisms of cognitive aging will allow identifying valid targets for therapeutic intervention.
Introduction
Although there is substantial evidence that decline in cognitive performance occurs with normal aging, the neurobiological basis of these age-related cognitive changes remains unclear. Crosssectional and longitudinal studies showed that across cognitive domains, memory performance undergoes significant decline with increasing age (Small et al., 1999) . Heritability estimates from twin and family studies indicate that genetic variants strongly influence cognitive ability differences throughout the life span, including in old age (Harris and Deary, 2011) . To date, however, most associations in or surrounding common variants are largely unreplicated, with the exception of the apolipoprotein E (APOE) gene (Wisdom et al., 2011) and have little biological support.
In our increasingly aging society, the population aged 60 years and older is set to rise 3-fold to 2 billion by 2050 (Publications, 2001) , consequently the burden of age-related cognitive impairment will increase. Characterizing genetic factors accounting for the age-related memory deficits will identify valid targets for therapeutic intervention to ameliorate cognitive impairment in the elderly individuals.
Recently, gene expression analysis of human postmortem tissue harvested from the hippocampal formation identified a substantial age-related decline in the expression of the histone-binding protein RbAp48 gene (Pavlopoulos et al., 2013) . Inhibition of RbAp48 in young genetically engineered mice caused memory deficits similar to those associated with aging, whereas increasing RbAp48 expression in old mice reversed age-related memory impairment.
Rbap48 gene is known to facilitate the action of the cyclic adenosine monophosphate responsive element binding protein (CREB)1 gene's-binding protein CREBBP, which is acetylates histones and affects age-related memory loss. In the present study, we investigated whether genetic variants in these histone acetylation pathway genes (RbAp48, CREBBP, and CREB1) influence memory performance in cognitive healthy elderly individuals.
Methods

Study cohorts
2.1.1. The National Institute of Aging Late-Onset Alzheimer's Disease
The National Institute of Aging Late-Onset Alzheimer's Disease Family Study was described elsewhere (Wijsman et al., 2011) . From the total cohort, 494 nondemented and unrelated healthy individuals were included in the present study. Episodic memory scores at the last cognitive assessment were computed as the average of the 2 standardized measures of Logical Memory IA and IIA (Wechsler, 1987) . Genome-wide genotyping was performed using Illumina Human610Quadv1_B BeadChips (Illumina, San Diego, CA, USA) (Naj et al., 2011) .
The Alzheimer's Disease Genetic Consortium
A total of 1744 cognitively normal elderly individuals from Alzheimer's Disease Genetic Consortium (ADGC) cohort consisting of 5 different independent NIA-funded Alzheimer's disease centers (Naj et al., 2011) were used to test the association of histone acetylation pathway genes and episodic memory performance. Episodic memory scores at the last cognitive assessment were computed as the average of the 2 standardized measures of Logical Memory IA and IIA (Wechsler, 1987) . Genome-wide genotyping was performed using various genotyping arrays (Saykin et al., 2010) . To test the possible association of the histone pathway genes and Alzheimer's disease, we additionally used a sample of 11,840 demented subjects from 15 different independent ADGC subcohorts.
The Washington Heights Aging Project
The Washington Heights Aging Project is a population-based study of elderly individuals residing in New York (Mayeux et al., 2001) . The memory domain included the total and delayed recall of the Selective Reminding Test (Buschke and Fuld, 1974) and the recognition component of the Benton Visual Retention Test (Benton, 1955) . The composite measure of memory was computed as the average of the standardized individual memory tests from the last cognitive assessment (Siedlecki et al., 2008) . Our analysis was restricted to the White subsample consisting of 436 cognitively healthy elderly individuals. Genome-wide genotyping was done using the Omni Express platform by Illumina.
Statistical methods
Imputed genotype data
To significantly improve the single-nucleotide polymorphism (SNP) coverage of the genes analyzed based on the different genome-wide association studies platforms, we used the imputed genotype data available for each of the study cohorts.
Genome-wide imputation of allele dosages within each of the study cohorts was performed using the worldwide reference panel (v3, released March 2012) from 1000 Genomes for imputation of genotypes (build 37, http://www.1000genomes.org/announcements/ updated-integrated-phase-1-release-calls-2012-03-16) and the IMPUTE2 (http://mathgen.stats.ox.ac.uk/impute/impute_v2.html) software applying strict pre-phasing, pre-imputation filtering, and variant position and strand alignment control. Only imputed SNP dosages with an imputation quality estimate of R 2 ! 0.30 were included in the final SNP set for analysis.
Tagging SNPs
Using the tagger program implemented in Haploview 4.0 (Barrett et al., 2005) , tag-SNPs across the 3 genes were selected on the basis of linkage disequilibrium patterns observed in the Caucasian samples from the International HapMap Project (http:// hapmap.ncbi.nlm.nih.gov/). The tag-SNPs were selected within a 50-Kb region flanking either side of the gene to capture all alleles with a correlation coefficient r 2 ! 0.8.
Single-marker tests of association
Regression models adjusted for sex, age, and education were conducted in the 3 different cohorts using PLINK (Purcell et al., 2007) . In each of the cohorts, interaction analysis between SNP markers significant in single-marker association tests and the APOE locus (coded as 0 or 1 based on the absence or the presence of e4 allele) was performed using linear regression analyses which modeled the main effect of both loci, an interaction term of the SNP Â APOE, and covariates (sex, age, and education).
Statistical significance
Multiple testing adjustment of the obtained p-values was carried out using The Genetic Type I error calculator tool (Li et al., 2012) to compute gene-specific thresholds of significance based on the number of SNPs used to tag (tag-SNPs) each of the analyzed genes: 37 tag-SNPs in CREB1 (p 0.001), 98 tag-SNPs in CREBBP (p 5 Â 10 À4 ), and 40 tag-SNPs in RBBP4 (p 0.001).
2.3.3. Meta-analysis SNP association with episodic memory performance was obtained from the 3 independent cohorts and combined by metaanalysis using METAL (Willer et al., 2010) . Results obtained from SNP-APOE interaction models within each cohort were also metaanalyzed. Because of the known APOE-e4 association with impaired cognitive performance (Mayeux et al., 2001 ) and the suggestive interaction between the most significant SNP and APOE locus (p meta ¼ 0.07), we stratified our analysis by APOE classifying the cohort's participants as carriers of 1, 2, or no copies of APOE-e4 allele.
Results
The strongest genetic association with episodic memory performance was observed for intronic SNP rs2526690 in CREBBP, reaching statistical significance after adjusting for multiple testing (p meta ¼ 3.7 Â 10 À4 ). When comparing the estimates of the beta coefficient of the SNP based on the APOE-e4 status, the SNP effect size appeared to be driven by the noncarriers of APOE-e4 allele (all subjects: b ¼ 0.20, standard error [SE] ¼ 0.07; APOE-e4 noncarriers b ¼ 0.13, SE ¼ 0.08).
Although not reaching statistically significant thresholds, 3 additional SNPs in CREBBP (rsrs36099109, rs112455953, and rs112193373) showed nominal associations that were directionally consistent across cohorts among individuals lacking the APOE-e4 allele (p meta ¼ 0.006, p meta ¼ 0.001, and p meta ¼ À0.002, respectively).
Within CREB1 gene proximity (39-Kb upstream the gene), SNP rs72954151 was found nominally associated with episodic memory (p meta ¼ 0.008) in the noncarriers of the APOE-e4 allele. SNP marker rs9660296 located 8-Kb upstream of RBBP4 gene appeared nominally associated with episodic memory performance (p meta ¼ 0.040) among noncarriers of APOE-e4. Table 1 summarizes all SNP associations with nominal p-values under any of the 3 APOE status models considered for analysis.
Analysis of the episodic memory associated SNPs in a cohort of 11,840 demented subjects from the ADGC did not identify any significant association (Table 2) , reinforcing the hypothesis that the association is not related to Alzheimer's disease but age-related memory impairment.
Discussion
We examined whether genetic variants in members of the cell signaling pathway, RbAp48, CREB1, and CREBBP, are associated with episodic memory performance in cognitively healthy elderly subjects. We identified an SNP in CREBBP significantly associated with episodic memory in meta-analyses of 3 independent cohorts (p meta ¼ 3. other genetic variants in RBBP4 and CREB1 also showed nominal associations (p meta 0.05) with episodic memory performance. Consistent with the idea that this signaling pathway is defective in age-related memory loss, our results show that genetic variation in these genes might be associated with memory performance in cognitively healthy elderly subjects. 
